Hepatic uptake of chylomicron remnants

Journal of Lipid Research

Volumn 38, Issue 11, 1997, Pages 2173-2192

  Cooper, Allen D ^a,b  

^a PALO ALTO MEDICAL FOUNDATION   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Chylomicron; Chylomicron remnants; Heparan sulfate proteoglycan; Hepatic lipase; LDL receptor; LDL receptor related protein

Indexed keywords

CHYLOMICRON; LIPOPROTEIN LIPASE;

ATHEROSCLEROSIS; ENZYME ACTIVITY; LIPID METABOLISM; LIPOGENESIS; LIPOLYSIS; LIVER METABOLISM; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ANIMALS; APOLIPOPROTEINS; CHYLOMICRONS; HUMANS; LIPASE; LIVER; MODELS, BIOLOGICAL; PHOSPHOLIPASES; PROTEOGLYCANS; RECEPTORS, LDL;

EID: 0030661590     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (200)

1. Havel, R. J., and R. L. Hamilton. 1988. Hepatocytic lipoprotein receptors and intracellular lipoprotein catabolism. Hepatology. 8: 1689-1704.
2. Mahley, R. W., and M. M. Hussain. 1991. Chylomicron and chylomicron remnant catabolism. Curr. Opin. Lipidol. 2: 170-176.
3. Cooper, A. D. 1992. Hepatic clearance of plasma chylomicron remnants. Semin. Liver Dis. 12: 386-396.
4. Gould, R. G., C. B. Taylor, and J. S. Hagerman. 1953. Cholesterol metabolism 1. Effect of dietary cholesterol on cholesterol synthesis in dog tissue in vitro. J. Biol. Chem. 210: 519.
5. Goodman, D. S. 1962. The metabolism of chylomicron cholesterol ester in the rat. J. Clin. Invest. 41: 1886-1896.
6. Stein, O., Y. Stein, D. S. Goodman, and N. H. Fidge. 1969. The metabolism of chylomicron cholesteryl ester in rat liver. A combined radioautographic-electron microscopic and biochemical study. J. Cell Biol. 43: 410-431.
7. Korn, E. D. 1955. Clearing factor, a heparin activated lipoprotein lipase. J. Biol. Chem. 215: 1-14.
8. Bergman, E. N., R. J. Havel, B. M. Wolfe, and T. Bøhmer. 1971. Quantitative studies of the metabolism of chylomicron triglycerides and cholesterol by liver and extrahepatic tissues of sheep and dogs. J. Clin. Invest. 50: 1831-1839.
9. Redgrave, T. G. 1970. Formation of cholesteryl ester-rich particulate lipid during metabolism of chylomicrons. J. Clin. Invest. 49: 465-471.
10. Mjos, O. D., O. Faergeman, R. L. Hamilton, and R. J. Havel. 1975. Characterization of remnants produced during the metabolism of triglyceride-rich lipoproteins in blood plasma and intestinal lymph in the rat. J. Clin. Invest. 56: 603-615.
11. Sparks, C. E., and J. B. Marsh. 1981. The metabolic heterogeneity of apolipoprotein B in the rat. J. Lipid Res. 22: 519-527.
12. Felts, J. M., H. Itakura, and R. T. Crane. 1975. The mechanism of assimilation of constituents of chylomicrons, very low density lipoproteins and remnants - a new theory. Biochem. Biophys. Res. Commun. 66: 1467-1475.
13. Noel, S., P. J. Dolphin, and D. Rubinstein. 1975. An in vitro model for the catabolism of rat chylomicrons. Biochem. Biophys. Res. Commun. 63: 764-772.
14. Sherrill, B. C., and J. M. Dietschy. 1978. Characterization of the sinusoidal transport process responsible for uptake of chylomicrons by the liver. J. Biol. Chem. 253: 1859-1867.
15. Cooper, A. D. 1977. The metabolism of chylomicron remnants by isolated perfused rat liver. Biochim. Biophys. Acta. 488: 464-474.
16. Cooper, A. D., and P. Y. S. Yu. 1978. Rates of removal and degradation of chylomicron remnants by isolated perfused rat liver. J. Lipid Res. 19: 635-643.
17. Sherrill, B. C., T. L. Innerarity, and R. W. Mahley. 1980. Rapid hepatic clearance of the canine lipoproteins containing only the E apoprotein by a high affinity receptor. Identity with the chylomicron remnant transport process. J. Biol. Chem. 255: 1804-1807.
18. Cooper, A., R. Nutik, and S. Erickson. 1980. Evidence that apoE is the determinant of chylomicron remnant binding to liver plasma membrane. Clin. Res. 28: 518.
19. Shelbourne, F., J. Hanks, W. Meyers, and S. Quarlfordt. 1980. Effect of apoproteins on hepatic uptake of triglyceride emulsions in the rat. J. Clin. Invest. 65: 652-658.
20. Windler, E., Y-S. Chao, and R. J. Havel. 1980. Determinants of hepatic uptake of triglyceride-rich lipoproteins and their remnants in the rat. J. Biol. Chem. 255: 5475-5480.
21. Brown, M. S., and J. L. Goldstein. 1986. A receptor-mediated pathway for cholesterol homeostasis. Science. 232: 34-47.
22. Cooper, A. D. 1996. Plasma lipoprotein metabolism. In Plasma Lipoprotein Metabolism. A. D. Cooper, editor. Kluwer Academic Publishers, Dordrecht, Netherlands. 97-126.
23. Bezman-Tarcher, A., S. Otway, and D. S. Robinson. 1964. The removal of triglyceride fatty acids from the circulation of the supradiaphragmatic portion of the rat. Proc. R. Soc. London Ser. B. 162: 406-410.
24. Fainaru, M., R. W. Mahley, R. L. Hamilton, and T. L. Innerarity. 1982. Structural and metabolic heterogeneity of beta-very low density lipoproteins from cholesterolfed dogs and from humans with type III hyperlipoproteinemia. J. Lipid Res. 23: 702-714.
25. Redgrave, T. G., R. C. Maranhao, A. M. Tercyak, E. C. Lincoln, and H. Brunengraber. 1988. Uptake of artificial model remnant lipoprotein emulsions by the perfused rat liver. Lipids. 23: 101-105.
26. Mortimer, B. C., W. J. Simmonds, C. A. Joll, R. V. Stick, and T. G. Redgrave. 1989. The effect of added monoacylglvcerols on the removal from plasma of chylomicron-like emulsions injected intravenously in rats. Biochim. Biophys. Acta. 1002: 359-364.
27. Martins, I. J., N. P. Lenzo, and T. G. Redgrave. 1989. Phosphatidylcholine metabolism after transfer from lipid emulsions injected intravenously in rats. Implications for high-density lipoprotein metabolism. Biochim. Biophys. Acta. 1005: 217-224.
28. Mortimer, B. C., W. J. Simmonds, S. J. Cockman, R. V. Stick, and T. G. Redgrave. 1990. The effect of monostearoylglycerol on the metabolism of chylomicron-like lipid emulsions injected intravenously in rats. Biochim. Biophys. Acta. 1046: 46-56.
29. Borensztajn, J., T. J. Kotlar, and B. J. McNeill. 1980. Uptake of phospholipid-depleted chylomicrons by the perfused rat liver. Biochem. J. 192: 845-851.
30. Borensztajn, J., and T. J. Kotlar. 1981. Hepatic uptake of phospholipid-depleted chylomicrons in vivo. Biochem. J. 200: 547-553.
31. Borensztajn, J., G. S. Getz, R. J. Padley, and T. J. Kotlar. 1982. The apoprotein B-independent hepatic uptake of chylomicron remnants. Biochem. J. 204: 609-612.
32. Borensztajn, J., T. J. Kotlar, and G. A. Matza. 1986. Heparin-binding apoproteins. Effects on lipoprotein lipase and hepatic uptake of remnants. Biochem. J. 233: 909-912.
33. Borensztajn, J., G. S. Getz, and T. J. Kotlar. 1988. Uptake of chylomicron remnants by the liver: further evidence for the modulating role of phospholipids. J. Lipid Res. 29: 1087-1096.
34. Borensztajn, J., and T. J. Kotlar. 1990. Phospholipids as modulators of hepatic recognition of chylomicron remnants. Observations with emulsified lipoprotein lipids. Biochem. J. 269: 539-542.
35. Borensztajn, J., T. J. Kotlar, and S. Chang. 1991. Apoprotein-independent binding of chylomicron remnants to rat liver membranes. Biochem. J. 279: 769-773.
36. Weisgraber, K. H., T. L. Innerarity, and R. W. Mahley. 1982. Abnormal lipoprotein receptor-binding activity of the human E apoprotein clue to cysteine-arginine interchange at a single site. J. Biol. Chem. 257: 2518-2521.
37. Zannis, V., J. L. Breslow, G. Utermann, R. W. Mahley, K. H. Weisgraber, R. J. Havel, J. L. Goldstein, M. S. Brown, G. Schonfeld, W. R. Hazzard, and G. Blum. 1982. Proposed nomenclature of apoE isoproteins, apoE genotypes, and phenotypes. J. Lipid Res. 23: 911-914.
38. Schaefer, E. J., R. E. Gregg, G. Ghiselli, T. M. Forte, J. M. Ordovas, L. A. Zech, and H. B. Brewer Jr. 1986. Familial apolipoprotein E deficiency. J. Clin. Invest. 78: 1206-1219.
39. Utermann, G., U. Langenbeck, U. Beisiegel, and W. Weber. 1980. Genetics of the apolipoprotein E system in man. Am. J. Hum. Genet. 32: 339-347.
40. Mahley, R. W. 1996. Heparan sulfate proteoglycan/low density lipoprotein receptor-related protein pathway involved in type III hyperlipoproteinemia and Alzheimer's disease. Israel J. Med. Sci. 32: 414-429.
41. Woollett, L. A., Y. Osono, J. Herz, and J. M. Dietschy. 1995. Apolipoprotein E competitively inhibits receptor-dependent low density lipoprotein uptake by the liver but has no effect on cholesterol absorption or synthesis in the mouse. Proc. Natl. Acad. Sci. USA. 92: 12500-12504
42. Weisgraber, K. H., R. W. Mahley, R. C. Kowal, J. Herz, J. L. Goldstein, and M. S. Brown. 1990. Apolipoprotein C-I modulates the interaction of apolipoprotein E with β-migrating very low density lipoproteins (β-VLDL) and inhibits binding of β-VLDL to low density lipoprotein receptor-related protein. J. Biol. Chem. 265: 22453-22459.
43. Aalto-Setala, K., K. A. Fisher, X. Chen, T. Chajek-Shaul, T. Hayek, R. Zechner, A. Walsh, R. Ramakrishnan, H. N. Ginsberg, and J. L. Breslow. 1992. Mechanism of hypertriglyceridemia in human apolipoprotein (apo) C-III transgenic mice. Diminished very low density lipoprotein fractional catabolic rate associated with increased apoC-III and reduced apoE on the particles. J. Clin. Invest. 90: 1889-1900.
44. Shachter, N. S., T. Hayek, T. Leff, J. D. Smith, D. W. Rosenberg, A. Walsh, R. Ramakrishnan, I. J. Goldberg, H. N. Ginsberg, and J. L. Breslow. 1994. Overexpression or apolipoprotein C-II causes hypertriglyceridemia in the transgenic mice. J. Clin. Invest. 93: 1683-1690.
45. Schachter, N. S., T. Ebara, R. Ramakrishnan, G. Steiner, J. L. Breslow, H. N. Ginsberg, and J. D. Smith. 1996. Combined hyperlipidemia in transgenic mice overexpressing human apolipoprotein C-I. J. Clin. Invest. 98: 846-855.
46. Chang, S., and J. Borensztajn. 1995. Uptake of chylomicron remnants and hepatic lipase-treated chylomicrons by a non-transformed murine hepatocyte cell line in culture. Biochim. Biophys. Acta. 1256: 81-87.
47. Chang, S., S. H. Zhang, N. Maeda, and J. Borensztajn. 1994. Hepatic clearance of chylomicron remnants in mice lacking apoprotein E. Biochim. Biophys. Acta. 1215: 205-208.
48. Jiang, J., Y. Fujioka, L. G. Fong, and A. D. Cooper. 1996. Normal clearance of chylomicron remnant by isolated liver of apoE-deficient mouse. Mol. Biol. Cell. 7(suppl): 660A.
49. Quarfordt, S. H., and D. S. Goodman. 1967. Metabolism of doubly-labeled chylomicron cholesteryl esters in the rat. J. Lipid Res. 8: 264-273.
50. Hussain, M. M., R. W. Mahley, J. K. Boyles, P. A. Lindquist, W. J. Brecht, and T. L. Innerarity. 1989. Chylomicron metabolism. Chylomicron uptake by bone marrow in different animal species. J. Biol. Chem. 264: 17931-17938.
51. de Faria, E., L. G. Fong, M. Komaromy, and A. D. Cooper. 1996. Relative roles of the LDL receptor, the LDL receptor-like protein, and hepatic lipase in chylomicron remnant removal by the liver. J. Lipid Res. 37: 197-209.
52. Fujioka, Y., L. G. Fong, and A. D. Cooper. 1997. Multiple receptors involved in the uptake of chylomicron remnants by mouse peritoneal macrophages. J. Invest. Med. 45: 106A.
53. Goldstein, J. L., and M. S. Brown. 1974. Binding and degradation of low density lipoproteins by cultured human fibroblasts. J. Biol. Chem., 249: 5153-5162.
54. Carrella, M., and A. D. Cooper. 1979. High affinity binding of chylomicron remnants to rat liver plasma membranes. Proc. Natl. Acad. Sci. USA. 76: 338-342.
55. Rubinsztein, D. C., J. C. Cohen, G. M. Berger, D. R. van der Westhuyzen, G. A. Coetzee, and W. Gevers. 1990. Chylomicron remnant clearance from the plasma is normal in familial hypercholesterolemic homozygotes with defined receptor defects. J. Clin. Invest. 86: 1306-1312.
56. Kovanen, P. T., S. K. Basu, J. L. Goldstein, and M. S. Brown. 1979. Low density lipoprotein receptors in bovine adrenal cortex. II. Low density lipoprotein binding to membranes prepared from fresh tissue. Endocrinolopy. 104: 610-616.
57. Kovanen, P. T., M. S. Brown, and J. L. Goldstein. 1979. Increased binding of low density lipoprotein to liver membranes for nus treated with 17 α-ethinyl estradiol. J. Biol. Chem. 254: 11367-11373.
58. Windler, K. K., P. T. Kovanen, Y. S. Chao, M. S. Brown, R. J. Havel, and J. L. Goldstein. 1980. The estradiol-stimulated lipoprotein receptor of rat liver. A binding site that mediates the uptake of rat lipoproteins containing apoproteins B and E. J. Biol. Chem. 255: 10464-10471.
59. Pittman, R. C., A. D. Attie, T. E. Carew, and D. Steinberg. 1979. Tissue sites of degradation of low density lipoprotein: application of a method for determining the fate of plasma proteins. Proc. Natl. Acad. Sci. USA. 76: 5345-5349.
60. Pittman, R. C., T. E. Carew, A. D. Attie, and D. Steinberg. 1982. Receptor-dependent and receptor-independent degradation of low density lipoprotein in normal rabbits and in receptor-deficient mutant rabbits. J. Biol. Chem. 257: 7994-8000.
61. Innerarity, T. L., and R. W. Mahley. 1978. Enhanced binding by cultured human fibroblasts of apoE-containing lipoproteins as compared with low density lipoproteins. Biochemistry. 17: 1440-1447.
62. Hoeg, J. M., S. J. Demosky, Jr., R. E. Gregg, E. J. Schaefer, and H. B. Brewer, Jr. 1985. Distinct hepatic receptors for low density lipoprotein and apolipoprotein E in humans. Science. 227: 759-761.
63. Mahley, R. W., D. Y. Hui, and T. L. Innerarity. 1981. Two independent lipoprotein receptors on hepatic membranes of dog, swine and man. J. Clin. Invest. 68: 1197-1206.
64. Hui, D. Y., W. J. Brecht, E. A. Hall, G. Friedman, T. L. Innerarity, and R. W. Mahley. 1986. Isolation and characterization of the apolipoprotein E receptor from canine and human liver. J. Biol. Chem. 261: 4256-4267.
65. Hui, D. Y., T. L. Innerarity, and R. W. Mahley. 1981. Lipoprotein binding to canine hepatic membranes. Metabolically distinct apoE and apoB,E receptors. J. Biol. Chem. 256: 5646-5655.
66. Floren, C-H., J. J. Albers, B. J. Kudchodkar, and E. L. Bierman. 1981. Receptor-dependent uptake of human chylomicron remnants by cultured skin fibroblasts. J. Biol. Chem. 256: 425-433.
67. Koo, C., M. E. Wernette-Hammond, Z. Garcia, M. J. Malloy, R. Uauy, C. East, D. W. Bilheimer, R. W. Mahley, and T. L. Innerarity. 1988. Uptake of cholesterol-rich remnant lipoproteins bv human monocyte-derived macrophages is mediated by low density lipoprotein receptors. J. Clin. Invest. 81: 1332-1340.
68. Ellsworth, J. L., F. B. Kraemer, and A. D. Cooper. 1987. Transport of β-very low density lipoproteins and chylomicron remnants by macrophages is mediated by the low density lipoprotein receptor pathway. J. Biol. Chem. 262: 2316-2325.
69. Fuki, I. V., S. N. Preobrazhensky, A. Y. Misharin, N. G. Bushmakina, G. B. Menschikov, V. S. Repin, and R. S. Karpov. 1989. Effect of cell cholesterol content on apolipoprotein B secretion and LDL receptor activity in the human hepatoma cell line, HepG2. Biochim. Biophys. Acta. 1001: 235-238.
70. Salter, A. M., M. Bugaut, J. Saxton, S. C. Fisher, and D. N. Brindley. 1987. Effects of preincubation of primary monolayer cultures of rat hepatocytes with low- and high-density lipoproteins on the subsequent binding and metabolism of human low-density lipoprotein. Biochem. J. 247: 79-84.
71. Edge, S. B., J. M. Hoeg, T. Triche, P. D. Schneider, and H. B. Brewer, Jr. 1986. Cultured human hepatocytes. Evidence for metabolism of low density lipoproteins by a pathway independent of the classical low density lipoprotein receptor. J. Biol. Chem. 261: 3800-3806.
72. Cooper, A. D., R. Nutik, and J. Chen. 1987. Characterization of the estrogen-induced lipoprotein receptor of rat liver. J. Lipid Res. 28: 59-68.
73. Fong, L. G., E. Bonney, J. C. Kosek, and A. D. Cooper. 1989. Immunohistochemical localization of low density lipoprotein receptors in adrenal gland, liver and intestine. J. Clin. Invest. 84: 847-856.
74. Cahill, P. D., G. E. Sarris, A. D. Cooper, P. D. Wood, J. C. Kosek, R. S. Mitchell, and D. C. Miller. 1988. Inhibition of vein graft intimal thickening by cicosapentanoic acid: reduced thromboxane production without change in lipoprotein levels or low-density lipoprotein receptor density. J. Vasc. Surg. 7: 108-118.
75. Sarris, G. E., J. I. Fann, M. H. Sokoloff, D. L. Smith, M. Loveday, J. C. Kosek, R. J. Stephens, A. D. Cooper, K. May, A. L. Willis, and D. C. Miller. 1989. Mechanisms responsible for inhibition of vein-graft arteriosclerosis by fish oil. Circulation. 80: 1109-1123.
76. Kita, T., J. L. Goldstein, M. S. Brown, Y. Watanabe, C. A. Hornick, and R. J. Havel. 1982. Hepatic uptake of chylomicron remnants in WHHL rabbits: a mechanism genetically distinct from the low density lipoprotein receptor. Proc. Natl. Acad. Sci. USA. 79: 3623-3627.
77. Bowler, A., T. G. Redgrave, and J. C. L. Mamo. 1991. Chylomicron-remnant clearance in homozygote and heterozygote Watanabe-heritable-hyperlipidaemic rabbits is defective. Biochem. J. 276: 381-386
78. Beaumont, J. L., and F. Assadollahi. 1990. Retinyl palmitate labeled intestinally derived lipoproteins accumulate in the circulation of WHHL rabbits. Atherosclerosis. 85: 103-111.
79. Hussain, M. M., T. L. Innerarity, W. J. Brecht, and R. W. Mahley. 1995. Chylomicron metabolism in normal, cholesterol-fed, and Watanabe heritable hyperlipidemic rabbits. J. Biol. Chem. 270: 8578-8587.
80. Choi, S. Y., L. G. Fong, M. J. Kirven, and A. D. Cooper. 1991. Use of an anti-LDL receptor antibody to quantify the role of the LDL receptor in the removal of chylomicron remnants in the mouse in vivo. J. Clin. Invest. 88: 1173-1181.
81. 2-macroglobulin receptor in chylomicron remnant removal in the mouse in vivo. J. Biol. Chem. 268: 15804-15811.
82. Ishibashi, S., J. L. Goldstein, M. S. Brown, J. Herz, and D. K. Burns. 1994. Massive xanthomatosis and athero-sclerosis in cholesterol-fed low density lipoprotein receptor-negative mice. J. Clin. Invest. 93: 1885-1893.
83. Ishibashi, S., J. Herz, M. O. Maeda, J. L. Goldstein, and M. S. Brown. 1994. The two-receptor model of lipoprotein clearance: tests of the hypothesis in "knockout" mice lacking the low density lipoprotein receptor, apolipoprotein E, or both proteins. Proc. Natl. Acad. Sci. USA. 91: 4431-4435.
84. Willnow, T. E., Z. Sheng, S. Ishibashi, and J. Herz. 1994. Inhibition of hepatic chylomicron remnant uptake by gene transfer of a receptor antagonist. Science. 264: 1471-1474.
85. Willnow, T. E., S. A. Armstrong, R. E. Hammer, and J. Herz. 1995. Functional expression of low density lipoprotein receptor-related protein is controlled by receptor-associated protein in vivo. Proc. Natl. Acad. Sci. USA. 92: 4537-4541.
86. Herz, J., S-Q. Qiu, A. Oesterle, H. V. DeSilva, S. Shafi, and R. J. Havel. 1995. Initial hepatic removal of chylomicron remnants is unaffected but endocytosis is delayed in mice lacking the low density lipoprotein receptor. Proc. Natl. Acad. Sci. USA. 92: 4611-4615.
87. Mortimer, B. C., D. J. Beveridge, I. J. Martins, and T. G. Redgrave. 1995. Intracellular localization and metabolism of chylomicron remnants in the livers of low density lipoprotein receptor-deficient mice and apoE-deficient mice. J. Biol. Chem. 270: 28767-28776.
88. Ishibashi, S., S. Perrey, Z. Chen, J. I. Osuga, M. Shimada, K. Ohashi, K. Harada, Y. Yazaki, and N. Yamada. 1996. Role of the low density lipoprotein (LDL) receptor pathway in the metabolism of chylomicron remnants. J. Biol. Chem. 271: 22422-22427.
89. Cabezas, M. C., T. W. A. de Bruin, L. A. W. Kock, W. Kortlandt, M. V. L.-S. Trip, H. Jansen, and D. W. Erkelens. 1993. Simvastatin improves chylomicron remnant removal in familial combined hyperlipidemia without changing chylomicron conversion. Metabolism. 42: 497-503.
90. Herz, J., U. Hamann, S. Rogne, O. Myklebost, H. Gausepohl, and K. K. Stanley. 1988. Surface location and high affinity for calcium of a 500 kD liver membrane protein closely related to the LDL-receptor suggest a physiological role as lipoprotein receptor. EMBO J. 7: 4119-4127.
91. 2-macroglobulin receptor and low density lipoprotein receptor-related protein suggests that this molecule is a multifunctional receptor. J. Biol. Chem. 265: 17401-17404.
92. Nimpf, J., S. Stifani, P. T. Bilous, and W. J. Schneider. 1994. The somatic cell-specific low density lipoprotein receptor-related protein of the chicken. J. Biol. Chem. 269: 212-219.
93. Kounnas, M. Z., R. E. Morris, M. R. Thompson, D. J. FitzGerald, D. K. Strickland, and C. B. Saelinger. 1992. The alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein binds and internalizes Pseudomonas exotoxin. J. Biol. Chem. 267: 12420-12423.
94. 2-macroglobulin receptor mediates cellular uptake of pro-urokinase. J. Biol. Chem. 268: 21862-21867.
95. Beisiegel, U., W. Weber, G. Ihrke, J. Herz, and K. K. Stanley. 1989. The LDL-receptor-related protein, LRP, is an apolipoprotein E-binding protein. Nature. 341: 162-164.
96. Jaeckle, S., S. E. Brady, and R. J. Havel. 1989. Membrane binding sites for plasma lipoproteins on endosomes from rat liver. Proc. Natl. Acad. Sci. USA. 86: 1880-1884.
97. Kowal, R. C., J. Herz, K. H. Weisgraber, R. W. Mahley, M. S. Brown, and J. L. Goldstein. 1990. Opposing effects of apolipoproteins E and C on lipoprotein binding to low density lipoprotein receptor-related protein. J. Biol. Chem. 265: 10771-10779.
98. 2-macroglobulin receptor. J. Biol. Chem. 266: 13936-13940.
99. Jackle, S., F. Rinninger, J. Greeve, H. Greten, and E. Windler. 1992. Regulation of the hepatic removal of chylomicron remnants and beta-very low density lipoproteins in the rat. J. Lipid Res. 33: 419-429.
100. Willnow, T. E., K. Orth, and J. Herz. 1994. Molecular dissection of ligand binding sites on the low density lipoprotein receptor-related protein. J. Biol. Chem. 269: 15827-15832.
101. 2-macroglobulin receptor-associated protein. Human homologue of a Heymann nephritis antigen. J. Biol. Chem. 266: 13364-13369.
102. Battev, F. D., M. E. Gafvels, D. J. FitzGerald, W. S. Argraves, D. A. Chappell, J. F. Strauss, III, and D. K. Strickland. 1994. The 39-kDa receptor-associated protein regulates ligand binding by the very low density lipoprotein receptor. J. Biol. Chem. 269: 23268-23273.
103. Medh J. D., G. L. Fry, S. L. Bowen, M. W. Pladet, D. K. Strickland, and D. A. Chappell. 1995. The 39-kDa receptor-associated protein modulates lipoprotein catabolism by binding to LDL receptors. J. Biol. Chem. 270: 536-540.
104. Jong, C., V. E. H. Dahlmans, P. J. J. van Gorp, K. W. van Dijk, M. L. Breuer, M. H. Hofker, and L. M. Havekes. 1996. In the absence of the low density lipoprotein receptor, human apolipoprotein C-I overexpression in transgenic mice inhibits the hepatic uptake of very low density lipoproteins via a receptor-associated protein-sensitive pathway. J. Clin. Invest. 98: 2259-2267.
105. Kris-Etherton, P. M., and A. D. Cooper. 1980. Studies on the etiology of the hyperlipemia in rats fed an atherogenic diet. Lipid Res. 21: 435-442.
106. Ashwell, G., and J. Harford. 1982. Carbohydrate-specific receptors of the liver. Annu. Rev. Biochem. 51: 531-554.
107. Bernini, F., S. R. Tanenbaum, B. C. Sherrill, A. M. Gotto, Jr., and L. C. Smith. 1986. Enhanced catabolism of low density lipoproteins in rat by lactosaminated fab fragment. J. Biol. Chem. 261: 9294-9299.
108. Attie, A. D., D. B. Weinstein, H. H. Freeze, R. C. Pittman, and D. Steinberg. 1979. Unaltered catabolism of desialylatred low-density lipoprotein in the pig and in cultured rat hepatocytes. Biochem. J. 180: 647-654.
109. Cooper, A. D., and D. Coleman. 1985. Chylomicron remnant and asialoglycoprotein metabolism are independent. Lipids. 20: 664-667.
110. Windier, E., J. Greeve, B. Levkau, V. Kolb-Bachofen, W. Daerr, and H. Greten. 1991. The human asialoglycoprotein receptor is a possible binding site for low-density lipoproteins and chylomicron remnants. Biochem. J. 276: 79-87.
111. Sakai, J., A. Hoshino, S. Takahashi, Y. Miura, H. Ishii, H. Suzuki, Y. Kawarabayasi, and T. Yamamoto. 1994. Structure, chromosome location, and expression of the human very low density lipoprotein receptor gene. J. Biol. Chem. 269: 2173-2182.
112. Niemeier, A., M. Gafvels, J. Heeren, N. Meyer, B. Angelin, and U. Beisiegel. 1996. VLDL receptor mediates the uptake of human chylomicron remnants in vitro. J. Lipid Res. 37: 1733-1742.
113. Bihain, B. E., and F. T. Yen. 1992. Free fatty acids activate a high-affinity saturable pathway for degradation of low-density lipoproteins in fibroblasts from a subject homozygous for familial hypercholesterolemia. Biochemistry. 31: 4628-4636.
114. Yen, F. T., C. J. Mann, L. M. Guermani, N. F. Hannouche, N. Hubert, C. A. Hornick, V. N. Bordeau, G. Aguani, and B. K. Bihain. 1994. Identification of a lipolysis-stimulated receptor that is distinct from the LDL receptor and the LDL receptor-related protein. Biochemistry. 33: 1172-1180.
115. Mann, C. J., J. Khallou, O. Chevreuil, A. A. Troussard, L. M. Guerniani, K. Launay, B. Delplanque, F. T. Yen, and B. E. Bihain. 1995. Mechanism of activation and functional significance of the lipolysis-stimulated receptor. Evidence for a role as chylomicron remnant receptor. Biochemistry. 34: 10421-10431.
116. Troussard, A. A., J. Khallou, C. J. Mann, P. Andre, D. K. Strickland, B. E. Bihain, and F. T. Yen. 1995. Inhibitory effect on the lipolysis-stimulated receptor of the 39-kDa receptor-associated protein. J. Biol. Chem. 270: 17068-17071.
117. Huettinger, M., H. T. Retzek, M. Eder, and H. Goldenberg. 1988. Characteristics of chylomicron remnant uptake into rat liver. Clin. Biochem. 21: 87-92.
118. van Berkel, T. J. C., J. K. Kruijt, and H-J. M. Kempen. 1985. Specific targeting of high density lipoproteins to liver hepatocytes by incorporation of a tris-galactoside-terminated cholesterol derivative. J. Biol. Chem. 260: 12203-12207.
119. 2-macroglobulin-recognition site. Biochem. J. 279: 863-870.
120. 2-macroglobulin (low density lipoprotein receptor-related protein) on rat parenchymal cells. J. Biol. Chem. 267: 17732-17737.
121. 2-macroglobulin receptor-associated protein, lactoferrin and transferrin on rat liver parenchymal cells. Biochem. Biophys. Acta. 1257: 288-292.
122. Ziere, G. J., J. K. Kruijt, M. K. Bijsterbosch, and T. J. C. van Berkel. 1996. Recognition of lactoferrin and amino-peptidase M-modified lactoferrin by the liver: involvement of proteoglycans and the remnant receptor. Biochem. J. 313: 289-295.
123. Breckenridge, W. C., J. A. Little, P. Alaupovic, C. S. Wang, A. Kuksis, G. Kakis, F. Lindgren, and G. Gardiner. 1982. Lipoprotein abnormalities associated with a familial deficiency of hepatic lipase. Atherosclerosis. 45: 161-179.
124. Borensztajn, J., and T. J. Kotlar. 1984. Liver uptake of chylomicron remnants with high and low apoprotein E:C ratios. Proc. Natl. Acad. Sci. USA. 81: 5863-5866.
125. Sultan, F., D. E. Lagrange, H. Jansen, and S. Griglio. 1990. Inhibition of hepatic lipase activity impairs chylomicron remnant-removal in rats. Biochim. Biophys. Acta. 1042: 150-152.
126. Ji, Z-S., S. J. Lauer, S. Fazio, A. Bensadoun, J. M. Taylor, and R. W. Mahley. 1994. Enhanced binding and uptake of remnant lipoproteins by hepatic lipase-secreting hepatoma cells in culture. J. Biol. Chem. 269: 13429-13436.
127. Lauer, S. J., Z-S. Ji, S. Fazio, A. Bensadoun, J. M. Taylor, and R. W. Mahley. 1993. Human hepatic lipase secretion by transfected McA-RH7777 cells results in enhanced binding and uptake of remnant lipoproteins. Circulation. 88: I-321.
128. Diard, P., M-I. Malewiak, D. Lagrange, and S. Griglio. 1994. Hepatic lipase may act as a ligand in the uptake of artificial chylomicron remnant-like particles by isolated rat hepatocytes. Biochem. J. 299: 889-894.
129. Choi, S. Y., M. C. Komaromy, J. Chen, L. G. Fong, and A. D. Cooper. 1994. Acceleration of uptake of LDL but not chylomicrons or chylomicron remnants by cells that secrete apoE and hepatic lipase. J. Lipid Res. 35: 848-859.
130. Komaromy, M., S. Azhar, and A. D. Cooper. 1996. Chinese hamster ovary cells expressing a cell surface-anchored form of hepatic lipase. J. Biol. Chem. 271: 16906-16914.
131. Ji, Z-S., W. J. Brecht, R. D. Miranda, M. M. Hussain, T. L. Innerarity, and R. W. Mahley. 1993. Role of heparan sulfate proteoglycans in the binding and uptake of apolipoprotein E-enriched remnant lipoproteins by cultured cells. J. Biol. Chem. 268: 10160-10167.
132. Ji, Z-S., S. Fazio, and R. W. Mahley. 1994. Variable heparan sulfate proteoglycan binding of apolipoprotein E variants may modulate the expression of type III hyperlipoproteinemia. J. Biol. Chem. 269: 13421-13428.
133. Ji, Z-S., D. A. Sanan, and R. W. Mahley. 1995. Intravenous heparinase inhibits remnant lipoprotein clearance from the plasma and uptake by the liver: in vivo role of heparin sulfate proteoglycans. J. Lipid Res. 36: 583-592.
134. Shafi, S., S. E. Brady, A. Bensadoun, and R. J. Havel. 1994. Role of hepatic lipase in the uptake and processing of chylomicron remnants in rat liver. J. Lipid Res. 35: 709-720.
135. Homanics, G. E., H. V. de Silva, J. Osada, S. H. Zhang, H. Wong, J. Borensztajn, and N. Maeda. 1995. Mild dyslipidemia in mice following targeted inactivation of the hepatic lipase gene. J. Biol. Chem. 270: 2974-2980.
136. Choi, S. 1996. An hepatic lipase-apoB interaction accelerates lipoprotein uptake. (Abstract). Circulation. Suppl. 94: I-399.
137. Beisiegel, U., W. Weber, and G. Bengtsson-Olivecrona. 1991. Lipoprotein lipase enhances the binding of chylomicrons to low density lipoprotein receptor-related protein. Proc. Natl. Acad. Sci. USA. 88: 8342-8346.
138. 2-macroglobulin receptor/low density lipoprotein receptor-related protein binds lipoprotein lipase and β-migrating very low density lipoprotein associated with the lipase. J. Biol. Chem. 268: 15048-15055.
139. 2-macroglobulin receptor in vivo. J. Biol. Chem. 268: 14168-14175.
140. Obunike, J. C., P. Sivaram, L. Paka, M. G. Low, and I. J. Goldberg. 1996. Lipoprotein lipase degradation by adipocytes: receptor-associated protein (RAP)-sensitive and proteoglycan-mediated pathways. J. Lipid Res. 37: 2439-2449.
141. Zambon, A., I. Schmidt, U. Beisiegel, and J. D. Brunzell. 1996. Dimeric lipoprotein lipase is bound to triglyceride-rich plasma lipoproteins. J. Lipid Res. 37: 2394-2404.
142. Ji, Z-S., and R. W. Mahley. 1994. Lactoferrin binding to heparan sulfate proteoglycans and the LDL receptor-related protein: further evidence supporting the importance of direct binding of remnant lipoproteins to HSPG. Arterioscler. Thromb. 14: 2025-2032.
143. Fraser, R., B. R. Dobbs, and G. W. T. Rogers. 1995. Lipoproteins and the liver sieve: the role of the fenestrated sinusoidal endothelium in lipoprotein metabolism, atherosclerosis, and cirrhosis. Hepatology. 21: 863-874.
144. Wisse, E., R. B. de Zanger, P. van der Smissen, and R. S. McCuskey. 1985. The liver sieve: considerations concerning the structure and function of endothelial fcnestrae, the sinusoidal wall and the space of disse. Hepatology. 5: 683-692.
145. Windler, E., J. Greeve, H. Robenek, F. Rinninger, and H. Greten. 1996. Differences in the mechanisms of uptake and endocytosis of small and large chylomicron remnants by rat liver. Hepatology. 24: 344-351.
146. Hamilton, R. L., J. S. Wong, L. S. S. Guo, S. Krisans, and R. J. Havel. 1990. Apolipoprotein E localization in rat hepatocytes by immunogold labeling of cryothin sections. J. Lipid Res. 31: 1589-1603.
147. Donner, C. S., M. C. Komaromy, and A. D. Cooper. 1995. Use of a transfected transplantable hepatoma to evaluate the role of hepatic lipase on lipoprotein uptake in vivo. Gastroenterology. 108: A1059.
148. Arbeeny, C. M., and V. A. Rifici. 1984. The uptake of chylomicron remnants and very low density lipoprotein remnants by the perfused rat liver. J. Biol. Chem. 259: 9662-9666.
149. Cooper, A. D., M. A. Shrewsbury, and S. K. Erickson. 1982. Comparison of binding and removal of remnants of triglyceride-rich lipoproteins of intestinal and hepatic origin by rat liver in vitro. Am. J. Physiol. 243: G389-395.
150. Redgrave, T. G., and D. A. Snibson. 1977. Clearance of chylomicron triacylglycerol and cholesteryl ester from the plasma of streptozotocin-induced diabetic and hypercholesterolemic hypothyroid rats. Metabolism. 26: 493-503.
151. Ross, A. C., and D. B. Zilversmit. 1977. Chylomicron remnant cholesteryl esters as the major constituent of very low density lipoproteins in plasma of cholesterol-fed rabbits. J. Lipid Res. 18: 169-181.
152. Floren, C-H., R. S. Kushwaha, W. R. Hazzard, and J. J. Albers. 1981. Estrogen-induced increase in uptake of cholesterol-rich very low density lipoproteins in perfused rabbit liver. Metabolism. 30: 367-375.
153. Redgrave, T. G., and M. J. Callow. 1990. The effect of insulin deficiency on the metabolism of lipid emulsion models of triacylglycerol-rich lipoproteins in rats. Metabolism. 39: 1-10.
154. Jensen, E., C-H. Floren, and A. Nilsson. 1988. Insulin stimulates the uptake of chylomicron remnants in cultured rat hepatocytes. Eur. J. Clin. Invest. 18: 226-232.
155. Mazzone, T., D. Foster, and A. Chait. 1984. In vivo stimulation of low-density lipoprotein degradation by insulin. Diabetes. 33: 333-338.
156. Wade, D. P., B. L. Knight, and A. K. Soutar. 1988. Hormonal regulation of low-density lipoprotein (LDL) receptor activity in human hepatoma HepG2 cells. Insulin increases LDL receptor activity and diminishes its suppression by exogenous LDL. Eur. J. Biochem. 174: 213-218.
157. Redgrave, T. G., C. L. Elsegood, J. C. L. Mamo, and M. J. Callow. 1991. Effects of hypothyroidism on the metabolism of lipid emulsion models of triacylglycerol-rich lipoproteins in rats. Biochem. J. 273: 375-381.
158. Landin, B., and A. Nilsson. 1987. Factors affecting theimpaired hepatic uptake of chylomicron remnants in the cholestatic rat. Scand. J. Gastroenterol. 22: 225-232.
159. Larsson, B., and A. Nilsson. 1980. Inhibition of hepatic chylomicron remnant uptake in the cholestatic rat. Scand. J. Gastroenterol. 15: 959-967.
160. Cooper, A. D., and R. K. Ockner. 1974. Studies of hepatic cholesterol synthesis in experimental biliary obstruction. Gastroenterology. 66: 586-595.
161. Cooper, A. D., A. L. Jones, R. E. Koldinger, and R. K. Ockner. 1974. Selective biliary obstruction: a model for studies in cholestasis. Gastroenterology. 66: 574-585.
162. Siperstein, M. D. 1964. Deletion of the cholesterol-negative feedback system in liver tumors. Cancer Res. 24: 1108.
163. Siperstein, M. D., V. M. Fagan, and H. P. Morris. 1966. Further studies on the deletion of the cholesterol feedback system in hepatomas. Cancer Res. 26: 7-11.
164. Bell, J. J., T. E. Sargeant, and J. A. Watson. 1976. Inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in hepatoma tissue culture cells by pure cholesterol and several cholesterol derivatives. Evidence supporting two distinct mechanisms. J. Biol. Chem. 251: 1745-1758.
165. Barnard, G. F., S. K. Erickson, and A. D. Cooper. 1984. Lipoprotein metabolism by rat hepatomas: studies on the etiology of defective dietary feedback inhibition of cholesterol synthesis. J. Clin. Invest. 74: 173-184.
166. Barnard, G. F., S. K. Erickson, and A. D. Cooper. 1986. Regulation of lipoprotein receptors on rat hepatomas in vivo. Biochim. Biophys. Acta. 879: 301-312.
167. Barnard, G. F., S. K. Erickson, Y. Nagata, and A. D. Cooper. 1989. Reduced binding and removal of chylomicron remnants by ethionine-induced premalignant liver. Hepatology. 9: 731-739.
168. Hazzard, W. R., and E. L. Bierman. 1976. Delayed clearance of chylomicron remnants following vitamin-A-containing oral fat loads in broad-β disease (type III hyperlipoproteinemia). Metabolism. 25: 777-801.
169. Berr, F., and F. Kern, Jr. 1984. Plasma clearance of chylomicrons labeled with retinyl palmitate in healthy human subjects. J. Lipid Res. 25: 805-812.
170. Berr, F. 1992. Characterization of chylomicron remnant clearance by retinyl palmitate label in normal humans. J. Lipid Res. 33: 915-930.
171. Nakandakare, E. R., S. A. Lottenberg, H. C. Oliveira, M. C. Bertolami, K. S. Vasconcelos, G. Sperotto, and E. C. Quintao. 1996. Simultaneous measurements of chylomicron lipolysis and remnant removal using a doubly labeled artificial lipid emulsion: studies in normolipidemic and hyperlipidemic subjects. J. Lipid Res. 35: 143-152.
172. Redgrave, T. G., H. L. Ly, E. C. R. Quintao, C. F. Ramberg, and R. C. Boston. 1993. Clearance from plasma of triacylglycerol and cholesteryl ester after intravenous injection of chylomicron-like lipid emulsions in rat and man. Biochem. J. 290: 843-847.
173. Zilversmit, D. B. 1979. Atherogenesis: a postprandial phenomenon. Circulation. 60: 473-485.
174. Patsch, J. R., G. Miesenbock, T. Hopferwieser, V. Muhlberger, E. Knapp, J. K. Dunn, A. M. Gotto, Jr., and W. Patsch. 1992. Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state. Arterioscler. Thromb. 12: 1336-1345.
175. Weintraub, M., A. Burstein, T. Rassin, M. Liron, Y. Ringel, S. Cabili, M. Bhim, G. Peer, and A. Iaina. 1992. Severe defect in clearing postprandial chylomicron remnants in dialysis patients. Kidney Int. 42: 1247-1252.
176. Weintraub, M., Y. Ringel, T. Rassin, J. Arad, G. Bodner, and M. Liron. 1992. Octogenarian subjects have low postprandial levels of chylomicron remnants: a possible explanation for protection against atherosclerosis. J. Gerentol. 47: B209-B213.
177. Karpe, F., G. Steiner, K. Uffelman, T. Olivecrona, and A. Hamsten. 1994. Postprandial lipoproteins and progression of coronary atherosclerosis. Atherosclerosis. 106: 83-97.
178. Simons, L. A., T. Dwyer, J. Simons, L. Bernstein, P. Mock, N. S. Poonia, S. Balasubramaniam, D. Baron, J. Branson, J. Morgan, and P. Roy. 1987. Chylomicrons and chylomicron remnants in coronary artery disease: a case-control study. Atherosclerosis. 65: 181-189.
179. Weintraub, M. S., I. Grosskopf, T. Rassin, H. Miller, G. Charach, H. H. Rotmensch, M. Liron, A. Rubinstein, and A. Iaina. 1996. Clearance of chylomicron remnants in normolipidaemic patients with coronary artery disease: case control study over three years. Br. Med. J. 312: 936-939.
180. Chen, Y. D. I., S. Swami, R. Skowronski, A. Coulston, and G. M. Reaven. 1993. Differences in postprandial lipidemia between patients with normal glucose tolerance and non-insulin-dependent diabetes mellitus. J. Clin. Endocrinol. Metab. 76: 172-177.
181. Chen, Y. D. I., R. Skowronski, A. M. Coulston, J. Pietarinen, C. B. Hollenbeck, and G. M. Reaven. 1992. Effect of acute variations in dietary fat and carbohydrate intake on retinyl ester content of intestinally derived lipoproteins. J. Clin. Endocrinol. Metab. 74: 28-32.
182. Chen, Y. D. I., S. Swami, R. Skowronski, A. M. Coulston, and G. M. Reaven. 1993. Effect of variation in dietary fat and carbohydrate intake on postprandial lipemia in patients with non-insulin-dependent diabetes mellitus. J. Clin. Endocrinol. Metab. 76: 347-351.
183. Jeppesen, J., Y. D. I. Chen, M. Y. Zhou, and G. M. Reaven. 1994. Effect of metformin on postprandial lipemia in patients with fairly to poorly controlled NIDDM. Diabetes Care. 17: 1093-1099.
184. Chen, Y-D. I., A. M. Coulston, M-Y. Zhou, C. B. Hollenbeck, and G. M. Reaven. 1995. Why do low-fat high-carbohydrate diets accentuate postprandial lipemia in patients with NIDDM? Diabetes Care. 18: 10-16.
185. Jeppesen, J., Y-D. I. Chen, M-Y. Zhou, P. Schaaf, A. Coulston, and G. M. Reaven. 1995. Postprandial triglyceride and retinyl ester responses to oral fat: effects of fructose. Am. J. Clin. Nutr. 61: 787-791.
186. Jeppesen, J., M-Y. Zhou, Y-D. I. Chen, and G. M. Reaven. 1994. Effect of glipizide treatment on postprandial lipaemia in patients with NIDDM. Diabetologia. 37: 781-787.
187. Wu, M-S., P. Johnston, W. H-H. Sheu, C. B. Hollenbeck, C-Y. Jeng, I. D. Goldfine, Y-D. I. Chen, and G. M. Reaven. 1990. Effect of metformin on carbohydrate and lipoprotein metabolism in NIDDM patients. Diabetes Care. 13: 1-8.
188. Jeppesen, J., M-Y. Zhou, Y-D. I. Chen, and G. M. Reaven. 1994. Effect of metformin on postprandial lipemia in patients with fairly to poorly controlled NIDDM. Diabetes Care. 17: 1093-1099.
189. Georgopoulos, A., and A. M. Rosengard. 1989. Abnormalities in the metabolism of postprandial and fasting triglyceride-rich lipoprotein subfractions in normal and insulin-dependent diabetic subjects: effects of sex. Metabolism. 38: 781-789.
190. Georgopoulos, A., D. Kafonek, and I. Raikhel. 1994. Diabetic postprandial triglyceride-rich lipoproteins increase esterified cholesterol accumulation in THP-1 macrophages. Metabolism. 43: 1063-1072.
191. Georgopoulos, A. 1994. Are chylomicron remnants involved in the atherogenesis of insulin-dependent diabetes mellitus? J. Lab. Clin. Med. 123: 640-646.
192. Georgopoulos, A., and C. D. Saudek. 1994. Intraperitoneal insulin delivery decreases the levels of chylomicron remnants in patients with IDDM. Diabetes Care. 17: 1295-1299.
193. Eriksson, M., B. Angelin, P. Henriksson, S. Ericsson, S. Vitols, and L. Berglund. 1991. Metabolism of lipoprotein remnants in humans. Arterioscler. Thromb. 11: 827-837.
194. Clifton, P. M., and P. J. Nestle. 1996. Effect of dietary cholesterol on postprandial lipoproteins in three phenotypic groups. Am. J. Clin. Nutr. 64: 361-367.
195. Ginsberg, H. N., W. Karmally, M. Siddiqui, S. Holleran, A. R. Tall, S. C. Rumsey, R. J. Deckelbaum, W. S. Blaner, and R. Ramakrishnan. 1994. A dose-response study of the effects of dietary cholesterol on fasting and postprandial lipid and lipoprotein metabolism in healthy young men. Arterioscler. Thromb. 14: 576-586.
196. Lewis, G. F., N. M. O'Meara, P. A. Soltys, J. D. Blackman, P. H. Iverius, A. F. Druetzler, G. S. Getz, and K. S. Polonsky. 1990. Postprandial lipoprotein metabolism in normal and obese subjects: comparison after the vitamin A fat-loading test. J. Clin. Endocrinol. Metab. 71: 1041-1050.
197. Lewis, G. F., N. M. O'Meara, P. A. Soltys, J. D. Blackman, P. H. Iverius, W. L. Pugh, G. S. Getz, and K. S. Polonsky. 1991. Fasting hypertriglyceridemia in non-insulin-dependent diabetes mellitus is an important predictor of postprandial lipid and lipoprotein abnormalities. J. Clin. Endocrinol. Metab. 72: 934-944.
198. Cabezas, M. C., T. W. de Bruin, H. Jansen, L. A. Kock, W. Kortlandt, and D. W. Erkelens. 1993. Impaired chylomicron remnant clearance in familial combined hyperlipidemia. Arterioscler. Thromb. 13: 804-814.
199. Weintraub, M. S., S. Eisenberg, and J. L. Breslow. 1987. Different patterns of postprandial lipoprotein metabolism in normal, type IIa, type III, and type IV hyperlipoproteinemic individuals. J. Clin. Invest. 79: 1110-1119.
200. Cortner, J. A., P. M. Coates, N-A. Le, D. R. Cryer, M. C. Ragni, A. Faulkner, and T. Langer. 1987. Kinetics of chylomicron remnant clearance in normal and in hyperlipoproteinemic subjects. J. Lipid Res. 28: 195-206.